Form D · Biotechnology
SENSEARLY INC.
Palo Alto, CA · CIK 0002059674
Offering snapshot reported Mar 11, 2025 · SEC filing
- Reported sold
- $1.7M Offering amount: $1.7M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Feb 25, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 11, 2025 | Initial | $1,700,000 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-540344
Series Seed-1 Preferred Stock and Series Seed-2 Preferred Stock and Common Stock issuable upon conversion of preferred stock.
Source: Form D, filed Mar 11, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Tushar Deepak Chandra | Director |
| Gangadhara Ganapati | Director, Executive |
| Anita Kohli | Director |
| G. Mani Subramanian | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2671 Marshall Drive
Palo Alto, CA, 94303
Palo Alto, CA, 94303